Indoco Remedies gets USFDA approval for Febuxostat Tab
Indoco Remedies gets USFDA approval for Febuxostat Tab

Indoco Remedies gets USFDA approval for Febuxostat Tab

Apurva Joshi Article rating: 5.0

Indoco Remedies has received the final USFDA approval of its ANDA for Febuxostat Tablets 40 mg and 80 mg, which is therapeutically equivalent to the reference listed drug (RLD), viz., Uloric Tablets 40 mg and 80 mg of Takeda Pharmaceuticals U.S.A., Inc.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

DSIJ Intelligence Article rating: 5.0

The market opened in the red on 31st December. On 30 December the Sensex was down by 17.14 points to end at 41,558.00 and the Nifty was up by 10.05 points to close at 12,255.80.  


Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

DSIJ Intelligence Article rating: 5.0

The market opened in the red on 31st December. On 30 December the Sensex was down by 17.14 points to end at 41,558.00 and the Nifty was up by 10.05 points to close at 12,255.80.  


Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

DSIJ Intelligence Article rating: 4.0

The market opened in the red on 31st December, overall volumes in futures & options currently stand at 1.49 crore contracts with a turnover of Rs. 10,76,944.88 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

DSIJ Intelligence Article rating: 4.4

The market opened in the red on 31st December, overall volumes in futures & options currently stand at 1.49 crore contracts with a turnover of Rs. 10,76,944.88 crore.


Thermax secures order of Rs 431 crore
Thermax secures order of Rs 431 crore

Thermax secures order of Rs 431 crore

Apurva Joshi Article rating: 5.0

Thermax Limited has bagged an order of Rs 431 crore from a public-private joint venture power company to set up two flue gas desulphurisation (FGD) systems at its thermal power plant in Jharkhand, India.

Route Mobile gets SEBI nod to float IPO
Route Mobile gets SEBI nod to float IPO

Route Mobile gets SEBI nod to float IPO

DSIJ Intelligence Article rating: 3.5
Messaging and voice application programming interface company, Route Mobile Ltd, has received the regulatory approval to float an initial public offering.
Chalet Hotels jumps on agreements with Marriott
Chalet Hotels jumps on agreements with Marriott

Chalet Hotels jumps on agreements with Marriott

Nidhi Jani Article rating: 4.5

This is one of the largest deals ever signed in the Indian luxury and upper‐upscale hotel tier and leverages historical synergies between Chalet and Marriott International.

Less pain, more gain: Use ulcer index
Less pain, more gain: Use ulcer index

Less pain, more gain: Use ulcer index

DSIJ Intelligence Article rating: 5.0

Depending on their needs and risk capacity, investors make use of various asset allocation strategies to create adequate wealth without much worry. Among such indices, the Ulcer index is an important one. In this article, we will discuss how it works and how beneficial it can prove to be.

RSS
First30953096309730983100310231033104Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR